Fulcrum Therapeutics (FULC) EPS (Basic): 2020-2025
Historic EPS (Basic) for Fulcrum Therapeutics (FULC) over the last 5 years, with Sep 2025 value amounting to -$0.31.
- Fulcrum Therapeutics' EPS (Basic) rose 11.43% to -$0.31 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.21, marking a year-over-year decrease of 317.24%. This contributed to the annual value of -$0.16 for FY2024, which is 89.94% up from last year.
- As of Q3 2025, Fulcrum Therapeutics' EPS (Basic) stood at -$0.31, which was down 10.71% from -$0.28 recorded in Q2 2025.
- Fulcrum Therapeutics' EPS (Basic)'s 5-year high stood at $0.89 during Q2 2024, with a 5-year trough of -$0.83 in Q2 2022.
- Its 3-year average for EPS (Basic) is -$0.23, with a median of -$0.36 in 2023.
- As far as peak fluctuations go, Fulcrum Therapeutics' EPS (Basic) surged by 334.21% in 2024, and later crashed by 131.46% in 2025.
- Quarterly analysis of 5 years shows Fulcrum Therapeutics' EPS (Basic) stood at -$0.58 in 2021, then climbed by 18.97% to -$0.47 in 2022, then climbed by 14.89% to -$0.40 in 2023, then soared by 32.50% to -$0.27 in 2024, then rose by 11.43% to -$0.31 in 2025.
- Its EPS (Basic) was -$0.31 in Q3 2025, compared to -$0.28 in Q2 2025 and -$0.27 in Q4 2024.